Urinary biomarker profiling in transitional cell carcinoma.
about
Discovery and validation of urinary biomarkers for prostate cancerA method for improving SELDI-TOF mass spectrometry data quality.SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerIncreased hepcidin expression in colorectal carcinogenesis.Integrated multi-level quality control for proteomic profiling studies using mass spectrometry.Approaching clinical proteomics: current state and future fields of application in fluid proteomics.Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer.High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urineProteomic patterns analysis with multivariate calculations as a promising tool for prompt differentiation of early stage lung tissue with cancer and unchanged tissue material.SELDI-TOF-MS proteomic profiling of serum, urine, and amniotic fluid in neural tube defects.Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer.Data mining in the Life Sciences with Random Forest: a walk in the park or lost in the jungle?An empirical assessment of validation practices for molecular classifiersDiscrimination of normal and esophageal cancer plasma proteomes by MALDI-TOF mass spectrometry.Statistical considerations of optimal study design for human plasma proteomics and biomarker discoveryProteomic study of benign and malignant pleural effusion.Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometryProteomic profiling of urine for the detection of colon cancer.Detection of tumours of the urinary tract in voided urine.Molecular markers for detection, surveillance and prognostication of bladder cancer.High throughput molecular diagnostics in bladder cancer - on the brink of clinical utility.Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids.Mass spectrometry-based proteomics of endoscopically collected pancreatic fluid in chronic pancreatitis researchUrine proteomics in kidney and urogenital diseases: Moving towards clinical applications.A proteomic comparison of formalin-fixed paraffin-embedded pancreatic tissue from autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer.Optimized sample preparation of endoscopic collected pancreatic fluid for SDS-PAGE analysis
P2860
Q30438582-37B662D4-1E56-44C5-A7FD-094216FF2E93Q31125985-24D34825-44AE-4DE6-BDF2-A9795D6E40EEQ33306300-A5066DE8-52C1-40F0-AAA9-F92693E8F183Q33322690-7F3236E6-217C-4F85-A534-D89E139AFFB3Q33389590-21A55D32-091A-46F8-96F3-37CB71C6051EQ33467523-05384D2B-89E1-4EFE-A914-42407C2F9817Q33597715-71AEDDD7-721B-4A68-8AB3-BA9C4CFA9ABCQ33610197-C143BA65-2195-4B7A-9CEB-9ED06B299AF8Q33850368-64E800C3-B5C7-4FDD-A105-C87F9B174F3CQ33940289-E974FD92-D2E4-402A-AB54-671DA006B578Q33976936-0460431C-E98E-475D-971D-8D05552FBA07Q34333936-963002DD-33A7-4F0A-83BE-348BBE490C04Q34933977-2FF518CD-1B89-4283-AC67-F64F241675D9Q35541147-6443EB2C-697C-4651-BD9A-402BFDD059B3Q35873957-0FDC9F8C-B355-4173-9E32-4E8EFE763B14Q35946652-65DC3F94-CACB-47E9-910D-752671B03547Q36011264-B30D6B4D-6444-4213-805E-445E51E1C09EQ36736959-C0DEE869-F1E2-4F7B-9BE6-7CB6D228E695Q37278998-2A83F6B4-F4C0-4C33-A590-B320B1CDF865Q37418122-F24E407E-D97C-44D0-B08E-505FE8AEDE95Q37453816-DF1FC39E-4338-47F9-A319-D4FBFD948175Q37484011-4B806F62-6371-47C2-BD73-87DCBC0E9DC9Q37810251-FDE2D8AE-F6B8-4847-9B60-6565BCC665F3Q37848311-15751ADA-296D-4448-8601-146DB9A9C0D0Q37876853-EF1CDFE4-7448-400A-AE36-9E9664C5BD23Q38395698-EAC3684C-B41B-4496-BE78-BBD31DA51A5CQ41985686-87296EB0-EDA1-4377-9097-7487B4A569E1
P2860
Urinary biomarker profiling in transitional cell carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Urinary biomarker profiling in transitional cell carcinoma.
@en
Urinary biomarker profiling in transitional cell carcinoma.
@en-gb
Urinary biomarker profiling in transitional cell carcinoma.
@nl
type
label
Urinary biomarker profiling in transitional cell carcinoma.
@en
Urinary biomarker profiling in transitional cell carcinoma.
@en-gb
Urinary biomarker profiling in transitional cell carcinoma.
@nl
prefLabel
Urinary biomarker profiling in transitional cell carcinoma.
@en
Urinary biomarker profiling in transitional cell carcinoma.
@en-gb
Urinary biomarker profiling in transitional cell carcinoma.
@nl
P2093
P2860
P50
P356
P1476
Urinary biomarker profiling in transitional cell carcinoma.
@en
P2093
Anthea J Stanley
Douglas Thompson
Ian Eardley
Margaret A Knowles
Mark Rogers
Nicholas P Munro
Patricia Harnden
Paul Clarke
P2860
P304
P356
10.1002/IJC.22238
P577
2006-12-01T00:00:00Z